|
NUPL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63239977091223E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.82210049668197E-10 |
| Normal-vs-Stage2 |
9.982300E-04 |
| Normal-vs-Stage3 |
1.803970E-04 |
| Normal-vs-Stage4 |
2.259900E-03 |
| Stage1-vs-Stage2 |
7.444000E-01 |
| Stage1-vs-Stage3 |
1.499970E-01 |
| Stage1-vs-Stage4 |
3.330200E-01 |
| Stage2-vs-Stage3 |
4.739400E-01 |
| Stage2-vs-Stage4 |
6.655200E-01 |
| Stage3-vs-Stage4 |
8.317000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.2335002170546E-10 |
| Normal-vs-AfricanAmerican |
3.638900E-03 |
| Normal-vs-Asian |
8.398700E-04 |
| Caucasian-vs-AfricanAmerican |
5.141400E-01 |
| Caucasian-vs-Asian |
6.677800E-01 |
| AfricanAmerican-vs-Asian |
4.302200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.43220000003996E-06 |
| Normal-vs-Female |
1.96730409740553E-11 |
| Male-vs-Female |
9.810300E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.245600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.86630002960453E-09 |
| Normal-vs-Age(61-80Yrs) |
7.76599999863237E-08 |
| Normal-vs-Age(81-100Yrs) |
2.877800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.487800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.311370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.442990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.261600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.453000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.053600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.015700E-03 |
| Normal-vs-Grade 2 |
2.12529993603994E-10 |
| Normal-vs-Grade 3 |
1.58610000000614E-06 |
| Normal-vs-Grade 4 |
3.739800E-02 |
| Grade 1-vs-Grade 2 |
2.982400E-02 |
| Grade 1-vs-Grade 3 |
1.937420E-03 |
| Grade 1-vs-Grade 4 |
1.138850E-03 |
| Grade 2-vs-Grade 3 |
6.587700E-02 |
| Grade 2-vs-Grade 4 |
1.732290E-02 |
| Grade 3-vs-Grade 4 |
2.249000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62814206561279E-12 |
| Normal-vs-ccB subtype |
4.318100E-03 |
| ccA subtype-vs-ccB subtype |
9.16790000027312E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.74500003125422E-09 |
| Normal-vs-N1 |
2.900600E-01 |
| N0-vs-N1 |
3.364400E-01 |
|
|
